Skip to main content

Table 1 Demographics and genetic testing results

From: Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program

Criteria   Number (%)
Gender Male 32 (31.4)
Female 70 (68.6)
Ethnicity White/Caucasian (non-Jewish) 89 (87.3)
White/Caucasian (Jewish) 12 (11.8)
Asian 1 (1.0)
Age   Mean (Range)
Overall 56 (35-78y)
Male 57 (37-78y)
Female 56 (35-72y)
Family history 1 FDR (plus 1 or more SDR) 38 (37.3)
2 FDR (+/− 1 or more SDR) 30 (29.4)
3 FDR (+/− 1 or more SDR) 11 (10.8)
BRCA2 (plus 1 or more relative with PC) 22 (21.6)
Clinical diagnosis of PJS 1 (1.0)
Genetic testing and previous malignancy
Not tested Total 31 (30.4)
(including PJS participant) None 30 (29.4)
Breast 1 (1.0)
No mutation identified Total 49 (48.0)
(Self or close affected relative) Nil cancer 42 (41.2)
Thyroid 1 (1.0)
Breast 5 (4.9)
Melanoma 1 (1.0)
BRCA2 carrier Total 22 (21.6)
  Nil cancer 10 (9.8)
Breast 5 (4.9)
Breast – Bilateral 4 (3.9)
Prostate 1 (1.0)
Prostate/Brain tumour 1 (1.0)
Melanoma 1 (1.0)
Smoking statusa Never smoked 56 (55.4)
Previous smoker 41 (40.6)
Current smoker 4 (4.0)
Alcohol consumptionb Non-drinker 17 (17.0)
Social drinker 19 (19.0)
Weekly drinker 36 (36.0)
Daily drinker 28 (28.0)
  1. a one data point not declared; b two data points not declared